Advil Liqui-Gels Solubilized Ibuprofen Capsules — Class II drug recall D-0566-2023
Ongoing recall by Family Dollar Stores, Llc., reported 2023-05-10, distributed nationwide. CGMP deviation: product outside labeled storage temperature requirements.
| Recall number | D-0566-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Family Dollar Stores, Llc., Chesapeake, VA, United States |
| Recall initiated | 2023-03-31 |
| Classified | 2023-05-04 |
| Reported by FDA | 2023-05-10 |
| Distributed | Nationwide (US) |
| Reason classes | labeling, cgmp |
Product
Advil Liqui-Gels Solubilized Ibuprofen Capsules, 200 mg Pain Reliever/Fever Reducer (NSAID) a) 20-count Liquid Filled Capsule bottles; b) 40-count Liquid Filled Capsule bottles.
Reason for recall
CGMP deviation: product outside labeled storage temperature requirements.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0566-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.